关注
Kyle John Wilby
Kyle John Wilby
Associate Professor of Program Evaluation, Dalhousie University
在 dal.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making
F Jibril, S Sharaby, A Mohamed, KJ Wilby
The Canadian journal of hospital pharmacy 68 (3), 238, 2015
1852015
Review of boceprevir and telaprevir for the treatment of chronic hepatitis C
KJ Wilby, N Partovi, JAE Ford, ED Greanya, EM Yoshida
Canadian Journal of Gastroenterology and Hepatology 26 (4), 205-210, 2012
1042012
A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients
KJ Wilby, ED Greanya, JAE Ford, EM Yoshida, N Partovi
Annals of hepatology 11 (2), 179-185, 2012
932012
The therapeutic effects of camel milk: a systematic review of animal and human trials
T Mihic, D Rainkie, KJ Wilby, SA Pawluk
Journal of evidence-based complementary & alternative medicine 21 (4), NP110 …, 2016
862016
Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review
EAG Lo, KJ Wilby, MHH Ensom
Annals of Pharmacotherapy 49 (2), 207-219, 2015
712015
Important steps for introducing interprofessional education into health professional education
A El-Awaisi, E Anderson, H Barr, KJ Wilby, K Wilbur, L Bainbridge
Journal of Taibah University Medical Sciences 11 (6), 546-551, 2016
642016
A review of pharmacokinetic drug–drug interactions with the anthelmintic medications albendazole and mebendazole
SA Pawluk, CA Roels, KJ Wilby, MHH Ensom
Clinical pharmacokinetics 54, 371-383, 2015
602015
A Middle Eastern journey of integrating Interprofessional Education into the healthcare curriculum: a SWOC analysis
A El-Awaisi, KJ Wilby, K Wilbur, MS El Hajj, A Awaisu, B Paravattil
BMC medical education 17, 1-10, 2017
592017
Therapeutic drug monitoring of voriconazole in the management of invasive fungal infections: a critical review
H Elewa, E El-Mekaty, A El-Bardissy, MHH Ensom, KJ Wilby
Clinical pharmacokinetics 54, 1223-1235, 2015
592015
Validation of a HPLC method for the determination of p-nitrophenol hydroxylase activity in rat hepatic microsomes
F Elbarbry, K Wilby, J Alcorn
Journal of Chromatography B 834 (1-2), 199-203, 2006
572006
Mosquirix (RTS, S): A Novel Vaccine for the Prevention of Plasmodium falciparum Malaria
KJ Wilby, TTY Lau, SE Gilchrist, MHH Ensom
The Annals of Pharmacotherapy 46 (3), 384-393, 2012
562012
Exploring facilitators and barriers to medication error reporting among healthcare professionals in Qatar using the theoretical domains framework: A mixed-methods approach
D Stewart, B Thomas, K MacLure, K Wilbur, K Wilby, A Pallivalapila, ...
PloS one 13 (10), e0204987, 2018
512018
A systematic review of antimicrobial stewardship interventions in the emergency department
M Losier, TD Ramsey, KJ Wilby, EK Black
Annals of Pharmacotherapy 51 (9), 774-790, 2017
512017
Evidence-based review of pharmacotherapy used for Parkinson’s disease psychosis
KJ Wilby, EG Johnson, HE Johnson, MHH Ensom
Annals of Pharmacotherapy 51 (8), 682-695, 2017
432017
A review of the effect of immunization programs on antimicrobial utilization
KJ Wilby, D Werry
Vaccine 30 (46), 6509-6514, 2012
432012
The impact of antimicrobial stewardship strategies on antibiotic appropriateness and prescribing behaviours in selected countries in the Middle East: a systematic review
Z Nasr, B Paravattil, KJ Wilby
World Health Organization, 2017
422017
A review of pharmacogenetics of antimalarials and associated clinical implications
H Elewa, KJ Wilby
European journal of drug metabolism and pharmacokinetics 42, 745-756, 2017
392017
Perspectives of healthcare professionals in Qatar on causes of medication errors: A mixed methods study of safety culture
D Stewart, B Thomas, K MacLure, A Pallivalapila, W El Kassem, A Awaisu, ...
PloS one 13 (9), e0204801, 2018
382018
A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline
TKL Kiang, KJ Wilby, MHH Ensom
Clinical pharmacokinetics 54, 915-931, 2015
362015
Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug–drug interactions
TKL Kiang, KJ Wilby, MHH Ensom
Clinical pharmacokinetics 52 (7), 487-510, 2013
332013
系统目前无法执行此操作,请稍后再试。
文章 1–20